arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

UTAH MEDICAL PRODUCTS INC

UTMD
$69.10 ▼ -3.20 (-4.43%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
68 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
82
Health
Excellent
Bullish
auto_awesome

Analytical Summary

UTAH MEDICAL PRODUCTS INC shows strong fundamentals with top-quartile Profit Margin (%) and Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $220.0M
Dividend Yield —
Revenue Growth -14.3% ↘
Op. Margin 31.1% ↗
ROIC 1.8% →
FCF / Share $0.39 ↘
Trailing P/E 82.3x
Price / Book 1.8x
FCF Yield 0.6%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$8.53M
↓ -14.3% —
Net Income Profit after all expenses
$2.60M
↓ -14.4% —
Operating Margin Operating profit as % of sales
31.1%
↑ +5.6% 86th
FCF / Share Free cash flow per share
$0.39
↓ -58.1% —
Long-Term Debt Long-term obligations
$0.00
— —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Profit Margin (%)Profit Margin (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↓
91
Returns ↓
66
Financial Health
97
Cash Quality ↓
75

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 68 quarters